Collectively, we demonstrated that decreased IDO1 activity could activate the p53 pathway by suppressing MDM2 expression and inhibit DLBCL cell growth by inducing the p53 apoptotic pathway and cell cycle arrest. Here, IDO1 is linked to diffuse large B-cell lymphoma.